Refractory Extensive Stage Lung Small Cell Carcinoma
1 clinical trials · Condition
◉ Watch Refractory Extensive Stage Lung Small Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer (NCT04607954) | Mayo Clinic | 2020-12-04 |
Track Refractory Extensive Stage Lung Small Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.